Search

Author/Creator Lagueny, A

1. A randomised, double blind, placebo controlled trial of botulinum toxin in the treatment of spastic foot in hemiparetic patients. Issue 3 (September 1996)

Authors:
Burbaud, P; Wiart, L; Dubos, J L; Gaujard, E; Debelleix, X; Joseph, P A; Mazaux, J M; Bioulac, B; Barat, M; Lagueny, A
Journal:
Journal of neurology, neurosurgery and psychiatry
Issue:
Volume 61:Issue 3(1996)
Page Start:
265
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Epsilon sarcoglycan mutations and phenotype in French patients with myoclonic syndromes. Issue 5 (14th October 2005)

Authors:
Tezenas du Montcel, S; Clot, F; Vidailhet, M; Roze, E; Damier, P; Jedynak, C P; Camuzat, A; Lagueny, A; Vercueil, L; Doummar, D; Guyant-Maréchal, L; Houeto, J-L; Ponsot, G; Thobois, S; Cournelle, M-A; Durr, A; Durif, F; Echenne, B; Hannequin, D; Tranchant, C
Other Names:
group-author.
Journal:
Journal of medical genetics
Issue:
Volume 43:Issue 5(2006)
Page Start:
394
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Serum IgG antibodies to P0 dimer and 35 kDa P0 related protein in neuropathy associated with monoclonal gammopathy. Issue 9 (21st August 2003)

Authors:
Favereaux, A; Lagueny, A; Vital, A; Schmitter, J-M; Chaignepain, S; Ferrer, X; Labatut-Cazabat, I; Vital, C; Petry, K G
Journal:
Journal of neurology, neurosurgery and psychiatry
Issue:
Volume 74:Issue 9(2003)
Page Start:
1262
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗